SCHEMBL1492820

SCHEMBL1492820

COc1ccc(C)cc1NC(=O)Nc1ccc(-c2ccnc(C)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.65
MEN1 O00255 5/20 0.65
KMT2A Q03164 5/20 0.65
TP53 P04637 2/20 0.65
GAA P10253 1/20 0.65
MAPK1 P28482 1/20 0.65
ALDH1A1 P00352 2/20 0.62
RAB9A P51151 2/20 0.61
LMNA P02545 1/20 0.61
HTT P42858 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
CASP3 P42574 2/20 0.58
SENP7 Q9BQF6 2/20 0.58
SENP6 Q9GZR1 1/20 0.58
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
PSEN1 P49768 5/20 0.56
PSEN2 P49810 5/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492687 0.90 PORCN (0.60) MAPTMEN1KMT2ATP53GAA
SCHEMBL1492881 0.89 PSEN1 (0.56) MAPTMEN1KMT2ATP53GAA
SCHEMBL1493084 0.89 MEN1 (0.58) MAPTMEN1KMT2ATP53GAA
SCHEMBL1492989 0.87 SMN1; SMN2 (0.62) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL1492785 0.87 PSEN1 (0.57) MAPTMEN1KMT2ATP53GAA
SCHEMBL1492973 0.86 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492866 0.84 MEN1 (0.61) MAPTMEN1KMT2ATP53LMNA
SCHEMBL1493016 0.84 KDR (0.69) MAPTRAB9ASMN1; SMN2PSEN1PSEN2
SCHEMBL1492877 0.84 PSEN1 (0.61) MEN1KMT2ARAB9APSEN1PSEN2
SCHEMBL1492788 0.83 HTR2C (0.57) MAPTMEN1KMT2ATP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 MAPT 26/4885MEN1 3122/4885KMT2A 3895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.